Financial Conflicts of Interest in Medicine*
نویسندگان
چکیده
We use the geographic distance between a doctor’s office and drug company headquarters to instrument for the likelihood of pecuniary transfers, such as meals or speaking fees. Doctors tilt prescriptions in favor of the paying firm’s drugs, shifting away from both branded and generic substitutes. Larger transfers cause larger shifts in prescriptions. We explore two potential explanations: 1) persuasion and/or information flow, and 2) rent seeking. Payments increase prescriptions of branded drugs over generic equivalents, situations where information cannot play a large role. However, doctors residing in states known to be corrupt in other ways (e.g., electoral fraud) are much more sensitive to payments from the drug industry. * We have benefited from discussions with Anirban Basu, Daniel Carlat, Doug Conrad, Raymond Fisman, Dan Hamermesh, Ryan Hansen, Sheridan Titman and seminar participants at Harvard University, the University of Southern California, and the University of Washington. ‡ Contact: Joseph Engelberg, Rady School of Management, University of California at San Diego, (Email) [email protected] (Tel) (1) 858-822-7912; Christopher A. Parsons, Rady School of Management, University of California at San Diego, (Email) [email protected] (Tel) (1) 858534-8782; Nathan Tefft, School of Public Health, University of Washington, (Email) [email protected] (Tel) (1) 206-221-5897.
منابع مشابه
Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey
Background Systematic reviews are increasingly used to inform health policy-making. The conflicts of interest (COI) of the authors of systematic reviews may bias their results and influence their conclusions. This may in turn lead to misguided public policies and systems level decisions. In order to mitigate the adverse impact of COI, scientific journals require authors to disclose their COIs. ...
متن کاملThe vexing problem of guidelines and conflict of interest: a potential solution.
Issues of financial and intellectual conflict of interest in clinical practice guidelines have raised increasing concern. Professional organizations have responded by more rigorous regulation of conflict of interest. Nevertheless, tension remains between the competing goals of optimizing guideline quality by using the experience and insight of experts and ensuring that financial and intellectua...
متن کاملTowards Patient-Centered Conflicts of Interest Policy
Financial conflicts of interest exist between industry and physicians, and these relationships have the power to influence physicians’ medical practice. Transparency about conflicts matters for ensuring adequate informed consent, controlling healthcare expenditure, and encouraging physicians’ reflection on professionalism. The US Centers for Medicare & Medicaid Services (CMS) launched the Open ...
متن کاملFinancial Conflicts and Compatibility in Dual-Career Couples: A Phenomenological Study
Extended Abstract Introduction: The notion of the traditional family (the man working outside the home and the housewife working indoors) is fading away, so that there are families where both men and women are working as full-time employees (Musavi, Samavatyan, & Nouri, 2018). The lifestyle of a dual-career couple refers to a situation in which the couple plays different roles, with the couple...
متن کاملFinancial conflicts of interest in psychiatry FORUM: FINANCIAL CONFLICTS OF INTEREST IN PSYCHIATRY
The proliferating connections between physicians and the pharmaceutical industry have brought the credibility of clinical medicine to an unprecedented crisis (1). The public seems to be increasingly skeptical of clinical medicine, since corporate actions that have placed profit over public health have become regular news in the media (2). Medical journals have been defined by a former editor as...
متن کاملFinancial conflicts of interest among editorialists in high-impact journals
Prior studies have shown that financial relationships between editorialists and the biopharmaceutical industry are associated with increased likelihood of favorable descriptions of evidence, even when that evidence is unfavorable. How financial conflicts among editorialists should be managed—whether disclosure or recusal is necessary—has been a longstanding debate in medicine. In 1990 under edi...
متن کامل